STAT+: Amylyx endocrine drug succeeds in pivotal study
STAT News · LC · trust 48/100
In a Phase 3 trial of people with post-bariatric hypoglycemia, those taking the drug, avexitide, experienced a 55% reduction in the rate of serious low blood sugar events compared with…
Read the original at STAT News →
Open in TruthVane →